| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 06/28/2007 | WO2007072093A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/28/2007 | WO2007071055A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | WO2007047863A3 Crystals of laquinimod sodium, and process for the manufacture thereof |
| 06/28/2007 | US20070149567 Quinoline compounds |
| 06/28/2007 | US20070149566 e.g. 4-({(E)-4-[(2-carboxy-6-fluoro-4-quinolinyl)oxy]-2-butenyl}oxy)-6-fluoroquinoline-2-carboxylic acid; antidiabetic, hypoglycemic agent; type II diabetes, dyslipidaemia, obesity, arterial hypertension, atherosclerosis, microangiopathy, macroangiopathy, retinopathy, neuropathy or hyperglycaemia |
| 06/28/2007 | US20070149529 inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, autoimmune pathologies such as rheumatoid arthritis and atherosclerosis |
| 06/28/2007 | US20070149520 HCV Inhibitors And Methods Of Using Them |
| 06/28/2007 | CA2634491A1 Compositions and methods for modulating gated ion channels |
| 06/28/2007 | CA2632954A1 An improved process for the manufacture of montelukast sodium |
| 06/28/2007 | CA2629991A1 Quinoline derivatives useful in the treatment of mglur5 receptor-mediated disorders |
| 06/27/2007 | EP1801189A2 Synergistic lubricating oil composition containing a mixture of a benzo[b]perhydroheterocyclic arylamine and a diarylamine |
| 06/27/2007 | EP1801105A1 Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions |
| 06/27/2007 | EP1801104A2 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
| 06/27/2007 | EP1799648A1 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
| 06/27/2007 | EP1799215A2 Chemokine-binding heterocyclic compound salts, and methods of use thereof |
| 06/27/2007 | EP1799214A1 Non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 06/27/2007 | CN1989108A Method for producing carbostyryl compound |
| 06/27/2007 | CN1989106A N－羟基酰胺衍生物及其应用 N- hydroxyamide derivatives and their Applications |
| 06/27/2007 | CN1989100A Therapeutic compounds |
| 06/26/2007 | US7235690 Anthranilamides and methods of their use |
| 06/26/2007 | US7235674 3-Cyano-7-methoxy-4-(3-bromo-4,5-dimethoxyphenyl)-2-oxo-2H-chromene; 7-Amino-4-(3-bromo-4,5-dimethoxy-phenyl)-3-cyano-2-imino-2H-chromene; anticancer, antitumor agent |
| 06/26/2007 | US7235664 Potassium channel modulators; antiarrhythmia agents |
| 06/26/2007 | US7235566 Pyridinone derivatives for treatment of atherosclerosis |
| 06/26/2007 | US7235565 Quinoline and quinolinones 4-substituted with a 3-(hetero)cyclylcarbonyl-1-imidazolinyl or 3-(hetero)cyclylcarbonyl-1-imidazolinonyl group; treating diabetes, glomerulonephritis, endotoxic shock, psoriasis, and arthritis |
| 06/26/2007 | US7235558 Anticoagulant; cardiovascular disorders; restenosis |
| 06/26/2007 | US7235546 Therapeutic treatment of diabetes with a 4-[piperazine-1-yl]-1,2-dihydro-quinolines; treating tumor growth, glomerulonephritis, inflammation, malarial anemia, septic shock, tumor associated angiogenesis, vitreoretinopathy, psoriasis, graft versus host disease, atopic dermatitis |
| 06/21/2007 | WO2007069977A1 Alkylsulphonamide quinolines |
| 06/21/2007 | WO2007069268A2 A process for the preparation of substantially pure 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid derivatives |
| 06/21/2007 | WO2007069261A1 An improved process for the preparation of montelukast and its pharmaceutically acceptable salts |
| 06/21/2007 | WO2007068316A1 Hydroxyquinoline derivatives |
| 06/21/2007 | US20070142639 Process for production of amines |
| 06/21/2007 | US20070142638 Ornithine derivatives as prostaglandin e2 agonists or antagonists |
| 06/21/2007 | US20070142427 Noncyclic 1,3-Dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
| 06/21/2007 | US20070142420 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein |
| 06/21/2007 | US20070142393 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 06/21/2007 | US20070142381 Calcium receptor modulating agents |
| 06/21/2007 | US20070142373 Quinoline derivatives as phosphodiesterase inhibitors |
| 06/21/2007 | US20070141715 Quantitative method of determining beryllium or a compound thereof in a sample |
| 06/21/2007 | CA2634168A1 Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof |
| 06/21/2007 | CA2633908A1 Hydroxyquinoline derivatives useful for the treatment of tumors and cellular proliferation |
| 06/21/2007 | CA2633129A1 Alkylsulphonamide quinolines |
| 06/21/2007 | CA2571640A1 Benzo[b]perhydroheterocyclic arylamines and lubricating oil compositions |
| 06/21/2007 | CA2570680A1 Dibenzo[b]perhydroheterocyclic amines and lubricating oil compositions |
| 06/20/2007 | EP1798231A2 Intermediate products for the preparation of antibacterial compounds |
| 06/20/2007 | EP1798222A1 Binuclear metal complex, metal complex dye, photoelectric transducer and photochemical battery |
| 06/20/2007 | EP1797881A1 Medicinal composition |
| 06/20/2007 | EP1797039A1 Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts |
| 06/20/2007 | CN1984895A Synthesis and uses of synephrine derivatives |
| 06/20/2007 | CN1984892A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/20/2007 | CN1984876A Diamine beta2 adrenergic receptor agonists |
| 06/20/2007 | CN1984655A Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions |
| 06/19/2007 | US7232817 α- and β-amino acid hydroxyethlamino sulfonyl urea derivatives useful as retroviral protease inhibitors |
| 06/19/2007 | US7232616 Complex |
| 06/14/2007 | WO2007067489A1 Quinolone m1 receptor positive allosteric modulators |
| 06/14/2007 | US20070135643 Process for making montelukast and intermediates therefor |
| 06/14/2007 | US20070135642 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 06/14/2007 | US20070135633 producing pyridine-substituted indole compound by reacting an indole with pyridine having leaving group, in presence of heterogeneous-system platinum group metal catalyst on support, ligand (1,1'-bis(diphenylphosphino)ferrocene) and base; industrial scale, cost efficiency |
| 06/14/2007 | US20070135480 decyclization of {3-[(E)-2(7-chloro-2-quinolinyl)vinyl]phenyl}-4,5-dihydro-3H-benzo[c]thiepin-1-one by methylmagnesium halide with following conversion to montelukast |
| 06/14/2007 | US20070134729 Novel antibacterial agents |
| 06/14/2007 | DE102005059479A1 Hydroxychinolinderivate Hydroxyquinoline |
| 06/14/2007 | CA2632653A1 Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof in the treatment of cancer |
| 06/14/2007 | CA2631917A1 Quinolone m1 receptor positive allosteric modulators |
| 06/13/2007 | EP1299359B1 Chemical process for the extraction of 2-hydroxy pyridine derivatives, 2-hydroxyquinoline, and 2-hydroxybenzothiazole |
| 06/13/2007 | EP1214292B1 Tyrosine derivatives |
| 06/13/2007 | CN1980894A Compounds and compositions as PPAR modulators. |
| 06/13/2007 | CN1980858A Molten salts, method of their production and process for generating hydrogen peroxide |
| 06/12/2007 | US7230108 2- or 4-Substituted by a 2-pyridinyl or 2-thiazolyl group, e.g., 2-(2-Chlorobenzyloxy)-4-[N-5-carboxythiazol-2-yl)carbamoyl]-6-methylquinoline; useful in the treatment of type 2 diabetes and obesity |
| 06/12/2007 | US7230106 Process for the preparation of inhibitors of macrophage migration inhibitory factor |
| 06/12/2007 | US7230020 For therapy of metabolic disorders, such as diabetes and obesity, cardiovascular disorders, such as hypertension, glaucoma, inflammatory disorders, such as arthritis or asthma, immune disorders, bone disorders, such as osteoporosis, cancer |
| 06/12/2007 | US7230010 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same |
| 06/12/2007 | US7230001 Arylalkane, arylalkene and aryl azaalkane, medicaments containing said compounds and method for the production thereof |
| 06/12/2007 | US7229990 E.g., tert-Butyl-5-amino-2-methylthio-4-(3-methoxyphenyl)-quinazoline-6 -carboxamide; used in fertility regulation therapies. |
| 06/12/2007 | US7229988 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants |
| 06/12/2007 | US7229986 Melanin-concentrating hormone antagonist |
| 06/12/2007 | US7229980 Including salts and mixtures with deoxycholic acid, glycocholic acid, taurocholic acid; can be formulated into an oral preparation for swallowing without water as an orally disintegrating tablet for paroxetine. |
| 06/07/2007 | WO2007064749A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007064732A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | WO2007063925A1 2-aminobenzamide derivative |
| 06/07/2007 | WO2007063869A1 Process for production of highly pure quinolone compound |
| 06/07/2007 | WO2007045551A3 Renin inhibitors nitroderivatives |
| 06/07/2007 | WO2007041076A3 1,2,3,5-tetrahydro-cyclopental[c]quinolin-4-one derivatives as rxr agonists for the treatment of dyslipidemia, hypercholesterolemia and diabetes |
| 06/07/2007 | WO2006126939A8 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 06/07/2007 | US20070129378 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | US20070129363 N-type calcium channel antagonists for the treatment of pain |
| 06/07/2007 | US20070129357 Novel crystals of fluorobenzamide derivative |
| 06/07/2007 | US20070129349 Alpha, beta -peptide inhibitors; Alzheimer's disease; 2-(4-Chloro-benzenesulfonylamino)-3-phenyl-propionic acid methyl ester |
| 06/07/2007 | CA2632922A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2632921A1 Compounds for the treatment of inflammatory disorders and microbial diseases |
| 06/07/2007 | CA2629964A1 2-aminobenzamide derivative |
| 06/06/2007 | EP1791820A2 Enantioselective preparation of quinoline derivatives |
| 06/06/2007 | EP1791809A1 Substituted aniline derivatives |
| 06/06/2007 | CN1974557A 5-arylamino quinolyl-7,8-dione derivative and its application in preparing antibiotic medicine |
| 06/06/2007 | CN1974556A Process of producing refined quinoline with quinoline fraction as material |
| 06/05/2007 | US7227037 As intermediates for N-{3-cyano-7-ethoxy-6-quinolinyl}-alkenamides; oxidizing N-(5-alkoxy-2-methyl-4-nitrophenyl)acetamides using potassium permanganate in the presence of magnesium sulfate in aqueous sulfolane or pyridine |
| 06/05/2007 | US7226950 Sodium channel modulators |
| 06/05/2007 | US7226942 2-amino-4-functionalized tetralin derivatives and related glycogen phosphorylase inhibitors |
| 06/05/2007 | US7226929 drugs such as 6 -Chloro-N-{(3S)-1-[(1S)-1-methyl-2-oxo-2-piperidin-1-ylethyl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide, used as antithrombotic agents |
| 06/05/2007 | US7226740 nucleic acid or a poly(amino acid) samples and dyes in form of staining solution are combined for sufficient time to form dye-analyte complex and are illuminated with an appropriate wavelength whereby nucleic acid or a poly(amino acid) is detected |
| 06/05/2007 | CA2225528C Novel camptothecin analogues, preparation methods therefor, use thereof as drugs, and pharmaceutical compositions containing said analogues |
| 05/31/2007 | WO2007061130A1 Anti-tumor agent for multiple myeloma |